2022 annual financial data

Arbutus Biopharma Corporation 2022 Operating margin

Arbutus Biopharma Corporation 2022 operating margin with verified reported valu…

Direct answer

Operating margin was -167.75%.

Operating income was -65,456,000 USD and net income was -69,456,000 USD.
Operating cash flow was -35,356,000 USD.

Get free Arbutus Biopharma Corporation email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
39,019,000 USD
Operating income
-65,456,000 USD
Net income
-69,456,000 USD
Operating cash flow
-35,356,000 USD